SLDB FY 2016 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena

SLDBSolid Biosciences Inc.

$581M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$56,000

Operating Income

-$26M

Net Income

-$22M

EPS (Diluted)

$-16.80

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$21M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$41M

Total Liabilities

$79M

Stockholders' Equity

-$84M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$56,000	$0	—
Operating Income	-$26M	-$7M	-289.6%
Net Income	-$22M	-$6M	-237.8%